4 mg/ml
Trade Name
Fluxetyl
Oral solution
Request Type
New Registration
Drug Type
Generic
Approval Date
SFDA Approved Use
Indicated for treatment Adults with
·Major depressive episodes
·Obsessive-compulsive disorder
·Bulimia nervosa: Fluxetyl is indicated as a complement of psychotherapy for the reduction of binge-eating and purging activity.
Indicated for Children and adolescents aged 8 years and above
Moderate to severe major depressive episode, if depression is unresponsive to psychological therapy after 4-6 sessions. Antidepressant medication should be offered to a child or young person with moderate to severe depression in combination with a concurrent psychological therapy.
·Major depressive episodes
·Obsessive-compulsive disorder
·Bulimia nervosa: Fluxetyl is indicated as a complement of psychotherapy for the reduction of binge-eating and purging activity.
Indicated for Children and adolescents aged 8 years and above
Moderate to severe major depressive episode, if depression is unresponsive to psychological therapy after 4-6 sessions. Antidepressant medication should be offered to a child or young person with moderate to severe depression in combination with a concurrent psychological therapy.